Bruker (BRKR) Accumulated Expenses (2010 - 2025)

Bruker has reported Accumulated Expenses for 16 years, with the latest figure at $179.7 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses fell 4.31% year-over-year to $179.7 million; the trailing twelve-month figure through Dec 2025 stood at $179.7 million (down 4.31% YoY), and the FY2025 full-year result was $179.7 million, down 4.31% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $179.7 million, down from $187.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $187.8 million in Q4 2024, with the low at $8.4 million in Q4 2023.
• Historically, Accumulated Expenses has averaged $128.8 million across 5 years, with a median of $136.1 million in 2022.
• Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 93.83% — and 2024, when it surged 2135.71%.
• Bruker's Accumulated Expenses stood at $132.0 million in 2021, then advanced by 3.11% to $136.1 million in 2022, then plunged by 93.83% to $8.4 million in 2023, then surged by 2135.71% to $187.8 million in 2024, then fell by 4.31% to $179.7 million in 2025.
• The last three Accumulated Expenses figures came in at $179.7 million (Q4 2025), $187.8 million (Q4 2024), and $8.4 million (Q4 2023), per Business Quant data.